Gene: DLAT
Official Full Name: dihydrolipoamide S-acetyltransferaseprovided by HGNC
Gene Summary: This gene encodes component E2 of the multi-enzyme pyruvate dehydrogenase complex (PDC). PDC resides in the inner mitochondrial membrane and catalyzes the conversion of pyruvate to acetyl coenzyme A. The protein product of this gene, dihydrolipoamide acetyltransferase, accepts acetyl groups formed by the oxidative decarboxylation of pyruvate and transfers them to coenzyme A. Dihydrolipoamide acetyltransferase is the antigen for antimitochondrial antibodies. These autoantibodies are present in nearly 95% of patients with the autoimmune liver disease primary biliary cirrhosis (PBC). In PBC, activated T lymphocytes attack and destroy epithelial cells in the bile duct where this protein is abnormally distributed and overexpressed. PBC enventually leads to cirrhosis and liver failure. Mutations in this gene are also a cause of pyruvate dehydrogenase E2 deficiency which causes primary lactic acidosis in infancy and early childhood.[provided by RefSeq, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03320 | DLAT Knockout cell line (HeLa) | Human | DLAT | 1:3~1:6 | Negative | Online Inquiry |
KO03321 | DLAT Knockout cell line (HCT 116) | Human | DLAT | 1:2~1:4 | Negative | Online Inquiry |
KO03322 | DLAT Knockout cell line (HEK293) | Human | DLAT | 1:3~1:6 | Negative | Online Inquiry |
KO03323 | DLAT Knockout cell line (A549) | Human | DLAT | 1:3~1:4 | Negative | Online Inquiry |
DLAT Gene Knockout Cell Lines are specifically engineered cellular models designed to investigate the role of the DLAT gene in biological processes and diseases. The DLAT gene encodes the dihydrolipoamide acyltransferase, an essential component of the pyruvate dehydrogenase complex, which plays a crucial role in metabolic pathways such as the conversion of glycolytic end products into acetyl-CoA. By providing a targeted knockout of the DLAT gene, these cell lines allow researchers to dissect the functional impact of DLAT depletion on cellular metabolism, signaling, and disease mechanisms.
The core mechanism behind these cell lines involves the CRISPR-Cas9 gene-editing technology, which enables precise alterations in the genomic sequence. Researchers can study downstream metabolic consequences of DLAT in cell proliferation, differentiation, and apoptosis, contributing valuable insights into conditions such as cancer, metabolic disorders, and neurodegenerative diseases. These insights can lead to the identification of new therapeutic targets and the development of innovative treatments.
The significance of DLAT Gene Knockout Cell Lines extends beyond fundamental research; they have notable applications in drug discovery, pharmacogenomics, and biomarker development. Compared to traditional methods, these knockout models provide a more accurate representation of in vivo conditions, allowing for improved translational viability in preclinical studies.
What sets DLAT Gene Knockout Cell Lines apart from alternatives is their robustness, reproducibility, and ease of use in standard laboratory settings. They are designed to expedite research timelines while ensuring the integrity and reliability of experimental results.
The value of these cell lines to researchers and clinicians rests in their ability to enhance the understanding of DLAT-related pathways, ultimately helping to unlock new avenues of research and clinical application. With years of experience in providing high-quality genetic models, our company is dedicated to supporting scientific advancement with innovative products such as the DLAT Gene Knockout Cell Lines, ensuring researchers have the tools they need to drive discoveries forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.